Grandeur Peak Global Advisors’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-75,398
Closed -$1.29M 119
2021
Q2
$1.29M Buy
75,398
+45,800
+155% +$857K 0.06% 97
2021
Q1
$618K Sell
29,598
-11,765
-28% -$271K 0.03% 106
2020
Q4
$947K Sell
41,363
-5,487
-12% -$104K 0.05% 93
2020
Q3
$764K Hold
46,850
0.05% 92
2020
Q2
$634K Buy
+46,850
New +$545K 0.05% 91

Other funds holding XENT

Grandeur Peak Global Advisors's XENT Position: Q3 2021 in Review

Grandeur Peak Global Advisors sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 75,398 shares — an estimated $1.29M sold.

Grandeur Peak Global Advisors first reported a position in XENT in Q2 2020 and held it in 5 quarters. The position peaked at $1.29M in Q2 2021. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • Grandeur Peak Global Advisors reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
  • Grandeur Peak Global Advisors sold 75,398 Intersect ENT, Inc shares in Q3 2021, an estimated $1.29M.
  • Grandeur Peak Global Advisors first reported a position in Intersect ENT, Inc in Q2 2020 and held it in 5 quarters.
  • Grandeur Peak Global Advisors's Intersect ENT, Inc position peaked at $1.29M in Q2 2021.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on Grandeur Peak Global Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.